PROMO!
First order? Get 10% OFF with this code: 1storder
Thymosin Alpha-1 is an acetylated, 28-amino-acid polypeptide originally characterized from thymic tissue and derived from the prothymosin-alpha sequence.
Thymosin Alpha-1 (Tα1) is a peptide consisting of 28 amino acids and corresponds to the N-terminal section of the precursor protein prothymosin alpha; a characteristic structural element is the acetylation of the serine residue at the N-terminus. The naturally occurring peptide was first isolated and described from thymic tissue, and synthetic Tα1 can be prepared as a chemically defined peptide for use in laboratory investigations.
Structurally, Thymosin Alpha-1 is a relatively small, highly charged, and acidic peptide. In aqueous environments, it exhibits substantial conformational flexibility, while experimental NMR studies indicate that its secondary structure can change according to the surrounding molecular environment.
Research carried out in the laboratory on Tα1 has looked at peptide–membrane interactions, cellular signaling, protein interactions, and molecular regulatory pathways. Although studies that have been published have examined connections with signaling systems such as those related to the Toll-like receptors, Tα1 currently has no single receptor that is universally accepted and fully accounts for its molecular activity. It is therefore more accurate to say that its mechanism is multifactorial and is still the subject of ongoing investigation than to describe it as a simple receptor–ligand interaction.
For research purposes, Thymosin Alpha-1 is identified by its amino acid sequence, N-terminal acetylation and molecular profile. Purity and other analytical data are reported in the documentation supplied with each batch, providing the relevant information for laboratory assessment.
Thymosin Alpha-1 (Tα1) is a linear peptide made up of 28 amino acid residues; one of its characteristic molecular features is that its N-terminal serine is acetylated, whereas its C-terminus has a free carboxyl group. Studies of its primary structure showed that the peptide is a highly acidic molecule with an isoelectric point of about 4.2.
The molecular formula of the free peptide is C₁₂₉H₂₁₅N₃₃O₅₅ and its molecular weight is about 3108.3 g/mol; its sequence is Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH.
Since thymosin Alpha-1 has no cysteine residues, its molecular structure lacks intramolecular disulfide bonds. The relatively high amount of aspartic and glutamic acid residues is what gives the molecule its acidic character.
Structural studies indicate that Tα1 is highly conformationally flexible in aqueous solution rather than maintaining a single rigid three-dimensional structure. NMR and circular dichroism experiments have shown that more ordered conformations, including helical regions, can develop under particular membrane-like or solvent conditions.
Thymosin Alpha-1 (Tα1) has been studied in a number of molecular and cell-based systems, but it is not regarded as acting through a single, definitely identified receptor; the present body of experimental literature instead shows that there are several possible interactions with cellular membranes, pattern-recognition receptors, and downstream signaling pathways.
Toll-Like Receptor Signaling
Studies carried out in the laboratory have examined Tα1 in connection with Toll-like receptor (TLR) signaling, specifically that of TLR2 and TLR9. Experiments involving dendritic cells and cell models in which TLRs have been transfected have shown that there are changes in TLR-dependent signaling associated with Tα1. The MyD88 adaptor pathway has likewise been found to be a significant element in certain experimental systems.
Intracellular Signal Transduction
Downstream molecular studies have looked at signaling components such as NF-κB, p38 MAPK, and other pathways associated with MAPK. These pathways offer measurable biochemical endpoints which can be used to study the cellular responses linked to Tα1 under controlled experimental conditions.
Membrane Interaction
A further area of study involves the direct interactions between Tα1 and phospholipid membranes. NMR studies show that the peptide shows a preference for negatively charged regions of the membrane that have exposed phosphatidylserine. When these interactions take place, Tα1 can change from a relatively unstructured state in water to more ordered helical conformations.
Continuing Mechanistic Research
Since Tα1 is linked to a number of signaling systems and no single molecular receptor has yet been found to explain all of the experimental observations reported, its mechanism is still the subject of ongoing investigation. The research models involving membrane interactions, TLR-associated signaling, and downstream transcriptional pathways are seen as complementary rather than indicating a single mechanism that has been definitively established.
Overall, Tα1 provides a defined peptide for laboratory investigation of peptide–membrane interactions, receptor-associated signaling, and intracellular signal-transduction pathways.
This summary reflects findings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references.
Thymosin Alpha-1 (Tα1) has been investigated using model membrane systems to examine how its molecular conformation changes in different environments. NMR and circular dichroism studies indicate that Tα1 is relatively unstructured in aqueous solution but can adopt more ordered helical conformations in membrane-like environments.
Experimental research has looked in particular at the interactions between Tα1 and membranes which contain phosphatidylserine. According to NMR studies, there is a preference for interaction with the negatively charged areas of the membrane, thus offering a molecular model for the investigation of peptide–lipid recognition and membrane association.
In studies that are based on cells, Tα1 has been looked at in experimental systems involving signaling through the Toll-like receptors (TLR). Research employing dendritic-cell models has examined the TLR-associated pathways, including those involving MyD88, p38 MAPK, and NF-κB signaling, as measurable molecular endpoints.
Tα1 has been studied in human and murine dendritic-cell cultures to characterize changes in cellular signaling and molecular markers under controlled experimental conditions. Different TLR-associated experimental systems have produced distinct cellular responses, demonstrating the importance of the particular model and stimulus used.
Structural research has examined how solvent composition, membrane models and lipid environment influence Tα1 conformation. These experiments are useful for investigating relationships between peptide flexibility, secondary structure and molecular interactions without assuming a single fixed three-dimensional structure.
Because a single receptor that accounts for all reported Tα1-associated molecular responses has not been conclusively established, continuing research examines membrane association alongside potential receptor and signaling interactions. These studies provide experimental models for investigating the molecular basis of Tα1 activity while recognizing that its complete mechanism remains under investigation.
The peptide identity and chromatographic purity of Thymosin Alpha-1 (Tα1) should be confirmed by means of analytical verification. Reverse-phase high-performance liquid chromatography (RP-HPLC) may be employed to determine the purity and to separate the main peptide from any species that are associated with synthesis or degradation. RP-HPLC has specifically been used for the analytical characterization of synthetic Tα1.
Mass spectrometry, such as LC-MS or high-resolution MS, can be employed in order to compare the molecular species that are observed with the expected mass of Tα1; tandem mass spectrometry can also provide additional confirmation relating to the sequence.
Analytical assessment may also consider peptide-related impurities and modified species. LC-HRMS research has identified Tα1-related variants arising from processes including deamidation, amino-acid insertion or deletion, dimer formation and isomerization.
Each research batch should be supported by a batch-specific Certificate of Analysis, documenting identity, purity, analytical method, testing date, and lot information.
Store Thymosin Alpha-1 (Tα1) at 2–8°C, following the storage condition specified on the current batch-specific Certificate of Analysis. Keep the material in a properly sealed container and protect it from moisture, excessive heat, and unnecessary temperature fluctuations.
For laboratory handling, allow the sealed vial to reach room temperature before opening to help limit condensation. Close the container promptly after handling and return the material to the specified 2–8°C storage conditions.
Thymosin Alpha-1 (Tα1) corresponds to a naturally occurring 28-amino-acid, N-terminally acetylated peptide derived from prothymosin alpha. Chemically synthesized and recombinant forms can also be produced as defined materials for laboratory investigation.
Thymosin Alpha-1 corresponds to the N-terminal 28-amino-acid region of prothymosin alpha. Experimental work has demonstrated that N-terminally acetylated Tα1 can be generated through cleavage of recombinant prothymosin alpha.
N-terminal acetylation refers to the presence of an acetyl group on the N-terminal serine residue of Tα1. Mass-spectrometric research shows that this modification adds approximately 42 Da compared with the corresponding non-acetylated peptide.
Not under all experimental conditions. Structural studies indicate that Tα1 is relatively unstructured in aqueous solution, while more ordered conformations can develop in membrane-like or particular solvent environments. NMR studies have identified helical and β-turn regions under defined experimental conditions.
A single receptor that fully accounts for all reported molecular interactions of Tα1 has not been conclusively established. Its mechanism is therefore better presented as an area of continuing laboratory investigation rather than attributing all observed responses to one defined receptor.
RP-HPLC and mass spectrometry are commonly used when analyzing Thymosin Alpha-1. HPLC provides information about chromatographic purity, while mass spectrometry can be used to check molecular identity. MS/MS can provide further structural information, including confirmation of the peptide sequence.
Mass spectrometry can distinguish acetylated Tα1 from its non-acetylated counterpart through the expected approximately 42 Da mass difference. MS/MS sequencing can provide additional confirmation that the acetyl modification is located specifically on the N-terminal serine residue.
Analytical results relate to the individual batch being supplied, rather than the product name alone. Reviewing the batch Certificate of Analysis and supporting analytical data provides a record of the material's stated identity and purity at the time of testing.
Thymosin Alpha-1 is for laboratory research and analytical use only. It is not intended for human or animal consumption or administration, or for the diagnosis, treatment, cure, or prevention of any disease or medical condition. It is not intended for clinical, therapeutic, or veterinary use.
All information provided on this page is for scientific and research purposes only and should not be interpreted as medical advice or a recommendation for human or animal use.
